Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.51
-0.16 (-2.09%)
Apr 29, 2026, 10:36 AM EDT - Market open
Gyre Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 5.03 | 12.09 | -92.93 | 2.3 |
| Depreciation & Amortization | 2.52 | 1.59 | 1.11 | 1.13 |
| Loss (Gain) From Sale of Assets | 0 | 0.07 | 3.34 | 0 |
| Asset Writedown & Restructuring Costs | - | - | 83.1 | - |
| Loss (Gain) on Equity Investments | 0.08 | 0.04 | 1.31 | 0.25 |
| Stock-Based Compensation | 7.16 | 0.83 | 7.28 | 13.37 |
| Provision & Write-off of Bad Debts | -0.06 | 0.17 | -0.06 | 0.02 |
| Other Operating Activities | 4.55 | 4.44 | 6.02 | 1.4 |
| Change in Accounts Receivable | -10.81 | -5.26 | 0.29 | -7.92 |
| Change in Inventory | -3.63 | -2.14 | 1.75 | -0.88 |
| Change in Accounts Payable | 0.01 | -0.25 | 0.19 | -0.11 |
| Change in Income Taxes | 0.04 | -2.17 | 3 | -1.34 |
| Change in Other Net Operating Assets | -3.88 | -13.05 | 11.49 | 2.46 |
| Operating Cash Flow | 1.01 | -3.64 | 25.89 | 10.68 |
| Operating Cash Flow Growth | - | - | 142.50% | - |
| Capital Expenditures | -1.19 | -2.32 | -8.52 | -4.99 |
| Sale of Property, Plant & Equipment | 0.03 | 0.4 | 0.66 | - |
| Cash Acquisitions | - | - | 5.46 | - |
| Divestitures | - | - | -0.57 | - |
| Sale (Purchase) of Intangibles | -0.73 | -0.81 | -0.07 | -0.01 |
| Investment in Securities | -14.01 | -17.16 | -16.74 | -8.82 |
| Other Investing Activities | 15.43 | - | - | - |
| Investing Cash Flow | -0.47 | -19.88 | -19.76 | -13.81 |
| Issuance of Common Stock | 25.87 | 2.64 | - | - |
| Other Financing Activities | -1.49 | -0.54 | - | - |
| Financing Cash Flow | 24.38 | 2.1 | 2.5 | - |
| Foreign Exchange Rate Adjustments | 0.34 | -0.27 | -0.3 | -1.89 |
| Net Cash Flow | 25.26 | -21.7 | 8.33 | -5.03 |
| Free Cash Flow | -0.18 | -5.96 | 17.38 | 5.69 |
| Free Cash Flow Growth | - | - | 205.25% | - |
| Free Cash Flow Margin | -0.15% | -5.63% | 15.32% | 5.56% |
| Free Cash Flow Per Share | -0.00 | -0.06 | 0.26 | 0.07 |
| Cash Income Tax Paid | 5.62 | 8.52 | 6.35 | 6.31 |
| Levered Free Cash Flow | 1.95 | -6 | 20.67 | - |
| Unlevered Free Cash Flow | 1.95 | -6 | 20.67 | - |
| Change in Working Capital | -18.26 | -22.86 | 16.72 | -7.8 |
Source: S&P Capital IQ. Standard template.
Financial Sources.